Sihuan Pharma gains on NMPA approval for Dongyan Skin Booster
Sihuan Pharmaceutical Holdings Group shares gain 2.8% to HK$0.72 after China's NMPA approves five new specifications for its Dongyan Skin Booster.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.